EUCTR2010-019463-10-IT进行中（未招募）不适用
MULTICENTER PHASE II STUDY FOR THE EVALUATION OF BEVACIZUMAB, OXALIPLATIN AND CAPECITABINE IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - BOXE
AZIENDA OSPEDALIERA S. CARLO0 个研究点目标入组 44 人开始时间: 2010年5月10日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) diagnosis of colorectal cancer; 2) age >= 70 years; 3) measurable lesions; 4) no previous chemotherapy treatment; 5) life expectancy almost of 12 weeks.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Performance Status (ECOG)> 2; 2) >3 comorbidities; 3) previous chemotherapy for advanced disease; 4) brain metastasis; 5) other malignancies.
研究者
相似试验
进行中（未招募）
不适用
A PHASE 2, SINGLE ARM, MULTI-CENTER STUDY ON THE BENEFIT/COST/SAFETY PROFILE OF LOW-DOSE RITUXIMAB FOR REFRACTORY MIXED CRYOGLOBULINEMIA - NDMixed cryoglobulinemia (type II or III) associated with chronic HCV infection (positive serology and/or HCV viremia)MedDRA version: 9.1Level: LLTClassification code 10011474Term: CryoglobulinaemiaEUCTR2008-000086-38-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
进行中（未招募）
不适用
A MULTICENTER PHASE II STUDY TO EVALUATE ACTIVITY AND TOLERABILITY OF CISPLATIN (CDDP) AND FOTEMUSTINE (FTM) COMBINATION IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH BRAIN METASTASES. - PHASE II in NSCLC PATIENTS WITH BRAIN METASTASESON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH BRAIN METASTASESMedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2006-002769-38-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
进行中（未招募）
不适用
A PROSPECTIVE, MULTICENTER PHASE II STUDY EVALUATING PREDICTIVE FACTORS FOR LENALIDOMIDE TREATMENT RESPONSE IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. - Le.P.Re studyEUCTR2009-011225-14-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
进行中（未招募）
不适用
PHASE I-II MULTICENTER STUDY OF P210-B2A2 DERIVED PEPTIDE VACCINE IN CHRONIC MYELOID LEUKEMIA PATIENTS IN COMPLETE CYTOGENETIC RESPONSE WITH PERSISTENT MOLECULAR RESIDUAL DISEASE DURING IMATINIB TREATMENTChronic myeloid leukemiaEUCTR2008-001107-27-DEniversität Leipzig48
进行中（未招募）
不适用
Safety and efficacy of BEZ235 in patients with pancreatic neuroendocrine tumors (pNET)Adult patient in advanced pancreatic neuroendocrine tumorsMedDRA version: 14.1Level: LLTClassification code 10068916Term: Pancreatic neuroendocrine tumor metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000675-16-NLovartis Pharma Services AG150